National Library of Medicine; Notice of Meetings, 54778 [2011-22601]
Download as PDF
<![CDATA[
54778
Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices
Information about becoming a
member on an FDA advisory committee
can also be obtained by visiting FDA’s
Web site by using the following link:
https://www.fda.gov/
AdvisoryCommittees/default.htm.
SUPPLEMENTARY INFORMATION: FDA is
requesting nomination for voting
members on the Tobacco Products
Scientific Advisory Committee.
I. General Description of the Committee
Duties
The Tobacco Products Scientific
Advisory Committee (the Committee)
advises the Commissioner of Food and
Drugs (the Commissioner) or designee in
discharging responsibilities as they
relate to the regulation of tobacco
products. The Committee reviews and
evaluates safety, dependence, and
health issues relating to tobacco
products and provides appropriate
advice, information and
recommendations to the Commissioner.
II. Criteria for Voting Members
Members and the Chair are selected
by the Commissioner or designee from
among individuals knowledgeable in
the fields of medicine, medical ethics,
science, or technology involving the
manufacture, evaluation, or use of
tobacco products. Members will be
invited to serve for terms of up to 4
years. The Committee shall include nine
technically qualified voting members,
selected by the Commissioner or
designee. The nine voting members
shall be physicians, dentists, scientists,
or health care professionals practicing
in the area of oncology, pulmonology,
cardiology, toxicology, pharmacology,
addiction, or any other relevant
specialty.
erowe on DSK5CLS3C1PROD with NOTICES
III. Nomination Procedures
Any interested person may nominate
one or more qualified individuals for
membership on the advisory committee.
Self-nominations are also accepted.
Nominations must include a current,
complete resume or curriculum vitae for
each nominee, including current
business address and/or home address,
telephone number, and e-mail address if
available. Nominations must also
specify the advisory committee for
which the nominee recommended.
Nomination must also acknowledge that
the nominee is aware of the nomination
unless self-nominated. FDA will ask
potential candidates to provide detailed
information concerning such matters
related to financial holdings,
employment, and research grants and/or
contracts to permit evaluation of
possible sources of conflicts of interest.
VerDate Mar<15>2010
15:37 Sep 01, 2011
Jkt 223001
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: August 30, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2011–22548 Filed 9–1–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
Literature Selection Technical Review
Committee.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended because the premature
disclosure of journals as potential titles
to be indexed by the National Library of
Medicine and the discussions would
likely to significantly frustrate
implementation of recommendations.
Name of Committee: Literature Selection
Technical Review Committee.
Date: October 27–28, 2011.
Open: October 27, 2011, 9 a.m. to 11 a.m.
Agenda: Administrative.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20894.
Closed: October 27, 2011, 11 a.m. to 5 p.m.
Agenda: To review and evaluate journals
as potential titles to be indexed by the
National Library of Medicine.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20894.
Closed: October 28, 2011, 8:30 a.m. to 2
p.m.
Agenda: To review and evaluate journals
as potential titles to be indexed by the
National Library of Medicine.
Place: National Library of Medicine,
Building 38, 2nd Floor, Board Room, 8600
Rockville Pike, Bethesda, MD 20894.
Contact Person: Sheldon Kotzin, MLS,
Associate Director, Division of Library
Operations, National Library of Medicine,
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
8600 Rockville Pike, Building 38, Room
2W06, Bethesda, MD 20892, 301–496–6921,
kotzins@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program No. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS).
Dated: August 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–22601 Filed 9–1–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group,
Musculoskeletal Tissue Engineering Study
Section.
Date: September 29–30, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Jean D. Sipe, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4106,
E:\FR\FM\02SEN1.SGM
02SEN1
]]>Agencies
[Federal Register Volume 76, Number 171 (Friday, September 2, 2011)]
[Notices]
[Page 54778]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22601]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Literature Selection Technical Review Committee.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended because the premature disclosure of journals as
potential titles to be indexed by the National Library of Medicine and
the discussions would likely to significantly frustrate implementation
of recommendations.
Name of Committee: Literature Selection Technical Review
Committee.
Date: October 27-28, 2011.
Open: October 27, 2011, 9 a.m. to 11 a.m.
Agenda: Administrative.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20894.
Closed: October 27, 2011, 11 a.m. to 5 p.m.
Agenda: To review and evaluate journals as potential titles to
be indexed by the National Library of Medicine.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20894.
Closed: October 28, 2011, 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate journals as potential titles to
be indexed by the National Library of Medicine.
Place: National Library of Medicine, Building 38, 2nd Floor,
Board Room, 8600 Rockville Pike, Bethesda, MD 20894.
Contact Person: Sheldon Kotzin, MLS, Associate Director,
Division of Library Operations, National Library of Medicine, 8600
Rockville Pike, Building 38, Room 2W06, Bethesda, MD 20892, 301-496-
6921, kotzins@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program No. 93.879,
Medical Library Assistance, National Institutes of Health, HHS).
Dated: August 29, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-22601 Filed 9-1-11; 8:45 am]
BILLING CODE 4140-01-P
